When it comes to surgery, your doctor's leadership skills play a crucial role

medicalxpress - You're scheduled for surgery next week. You've likely looked up your surgeon's credentials, years of experience, and perhaps even patient reviews. You want reassurance that your surgeon has steady hands, deep expertise, and a thorough command of the proce…

AI Summary: New research links a surgeon’s leadership and team‑management skills to measurable differences in operating‑room performance and patient outcomes. Hospitals are being nudged to treat leadership training as clinical skill development rather than optional soft training — because apparently who’s in charge matters when someone’s insides are on the line.

Global study estimates over 250,000 meningitis deaths in 2023, with young children bearing a heavy toll

medicalxpress - In 2023, 259,000 people died from meningitis and 2.5 million people were infected with the disease globally, suggests a study published in The Lancet Neurology. Although death and infection rates have declined significantly since 1990, progress is insuffi…

AI Summary: A worldwide mortality analysis estimates more than 250,000 deaths from meningitis in 2023, with young children bearing the heaviest toll. The findings underline gaps in vaccination, surveillance and outbreak preparedness, and call for accelerated prevention efforts—particularly on campuses and in high‑risk populations—before the predictable heartbreak rolls around again.

Do you love sleeping with your pet? Science reveals there's a tricky trade‑off

medicalxpress - For some pet guardians, their pets are present in their lives from the moment they wake up to the moment they go to bed. This happens because cats, dogs and other companion animals are increasingly perceived as family members. I'm not talking about the di…

AI Summary: New research finds sleeping with pets can boost comfort and emotional wellbeing, but carries trade-offs: increased allergen exposure, more fragmented sleep and small infection risks. Experts advise weighing mental‑health gains against sleep quality and hygiene, and using pet‑free bedrooms when needed — because 'cute' is not a medical recommendation.

A gut microbe linked to the Mediterranean diet boosts muscle strength in mice

livescience - Researchers are exploring the prospect of using gut bacteria to boost muscle strength, after zeroing in on a microbe that does this in mice

AI Summary: Researchers identified a gut microbe associated with adherence to a Mediterranean-style diet that, when introduced to mice, improved muscle strength and mitochondrial-related signals. The findings suggest a microbiome-mediated pathway that could inform interventions for age-related muscle decline, though translation to humans remains unproven and will need careful clinical follow-up.

Two States Sue Cord Blood Bank Over False Advertisements

Sarah Kliff and Azeen Ghorayshi / nytimes - The attorneys general of Texas and Arizona contend that Cord Blood Registry, which stores umbilical cord cells, profited from misleading new parents.

AI Summary: Two state attorneys general filed lawsuits alleging a cord‑blood bank made false or misleading claims about the future therapeutic value of stored units. The actions seek consumer remedies and penalties, challenging marketing that regulators say may have led families to pay for services based on overstated promises about potential medical uses.

UK government recommends maximum two hours of screen time for younger children: What the evidence says

medicalxpress - New UK government guidance recommends that screen time for children under two should be avoided, except for shared activities such as video calls. For children aged two to five, a maximum of an hour a day is suggested. The guidance also outlines that watc…

AI Summary: The UK government updated child‑health guidance recommending strict limits on young children’s screen time, citing evidence linking excessive use to delayed development and poorer sleep. The guidance urges parents and caregivers to prioritize interactive, non‑screen activities and age‑appropriate limits while acknowledging modern practicalities for families.

FDA Approval for Denali Therapeutics Blazes a New Trail for Brain-Penetrating Drugs

Frank Vinluan / medcitynews - Denali Therapeutics’ Avlayah received FDA approval for treating Hunter syndrome, a rare neurological disorder. The biologic medicine uses Denali’s proprietary drug delivery technology to cross the protective blood-brain barrier. The post FDA Approval for …

AI Summary: Regulators granted Denali accelerated approval for a brain‑penetrant therapy, recognizing promising early efficacy in a rare neurological indication and addressing unmet needs in CNS drug delivery. The pathway requires confirmatory trials to verify clinical benefit while enabling earlier patient access to a novel mechanism targeting central nervous system disease.

FDA approves 1st weekly basal insulin for Type 2 diabetes

Ella Jeffries / beckershospitalreview - The FDA has approved Novo Nordisk’s Awiqli (insulin icodec-abae), making it the first once-weekly basal insulin available in the U.S. for adults with Type 2 diabetes. Awiqli is indicated as an adjunct to diet and exercise and is intended to reduce injecti…

AI Summary: The FDA approved the first once‑weekly basal insulin for adults with Type 2 diabetes, providing an alternative to daily injections and aiming to improve adherence and glycemic control. Regulators based the decision on trials showing comparable efficacy and safety to daily basal insulins, potentially reshaping diabetes management.

FDA approves Rocket's gene therapy for ultra-rare immune disease

Lei Lei Wu / endpoints - A rare disease gene therapy from Rocket Pharmaceuticals has garnered FDA approval after an earlier rejection for manufacturing problems. The FDA on Thursday granted accelerated approval to Rocket Pharma’s gene therapy ...

AI Summary: The FDA granted approval to Rocket’s gene therapy for a pediatric immune disorder, marking the first regulatory ok for this specific treatment class in children and offering a one‑time corrective option for affected patients. The decision opens access while raising expectations for long‑term follow‑up and real‑world safety monitoring.

Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows

medicalxpress - New evidence from a Chinese cohort presented at the European Lung Cancer Congress (ELCC) 2026 shows that one-time low-dose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in a non–risk based population, including indivi…

AI Summary: A large population‑based study found organized lung cancer screening reduced mortality even in people who never smoked, demonstrating the benefits of expanded CT screening criteria and systematic outreach. The results suggest screening programs can detect lethal disease earlier across broader risk groups, prompting reconsideration of current eligibility rules.